globalnews.ca
65%
242
USask’s Vido-InterVac nearing human clinical trials for COVID-19 vaccine
University of Saskatchewan’s vaccine research team could start clinical trials in December or January.VIDO-Intervac is in the final stages before the COVID-19 vaccine they are developing will be tested on people. After toxicology tests, Health Canada will need to approve the first two phases of clinical trials to ensure it is safe.“They’re also looking at some proof that the vaccine’s going to work,” said Dr.